Dermatological OTC Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Dermatological Over the Counter (OTC) Drugs Market is Segmented by Indication (Acne, Dermatitis, Psoriasis, Fungal Infections, and Others), Product (Tablets and Capsules, Oils, Gels, Creams, And Ointments, and Others) Route Of Administration (Oral and Topical), Distribution Channel (Hospital and Retail Pharmacies, Online Pharmacies, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Dermatological OTC Drugs Market Size

Compare market size and growth of Dermatological OTC Drugs Market with other markets in Healthcare Industry

Dermatological OTC Drugs Market Analysis

The Dermatological OTC Drugs Market is expected to register a CAGR of 4.3% during the forecast period.

The COVID-19 pandemic had a significant impact on the studied market. Some studies reported that COVID-19 was responsible for dermatological conditions. For instance, according to the research study published by the National Library of Medicine in June 2022, the pandemic has caused a marked increase in stress-responsive dermatological conditions such as telogen effluvium, psoriasis, eczema, urticaria, and atopic dermatitis. Further, with the onset of telemedicine during the pandemic, there has been a significant increase in the demand for dermatological treatment. For instance, according to an article published by the National Library of Medicine, in May 2021, the COVID-19 pandemic had a huge impact on dermatology, as evidenced by the reduction of nonessential visits and procedures and the emergence of teledermatology. Teledermatology solutions have demonstrated the ability to enhance health outcomes during a high-stress period like the COVID-19 pandemic. Thus, the COVID-19 pandemic has significantly impacted the market initally, but later on with the emergence of telemedicine, the market witnessed a significant growth.

The major factor driving the growth of the studied market is the rising prevalence of skin-related diseases, the aging population as well as increasing demand and availability of dermatological OTC drugs. For instance, according to the research study published by the British Journal of Dermatology, in February 2021, skin diseases are the fourth most common cause of all human diseases, which affects approximately one-third of the global population. Hence, dermatological OTC drugs are gaining traction around the world due to increasing out-of-pocket expenditure. Besides, OTC drugs are not only cheaper than prescribed drugs, but also they are easily available and do not need any medical consultation. Thus, they offer a better alternative to the prescribed drugs which involves doctor's consultation with additional charges and expensive products.

Furthermore, increasing demand and availability of dermatological OTC drugs are expected to drive the growth of the market over the forecast period. For instance, according to an article published by Dermatology Advisor, in September 2022, there is an increase in the accessibility of OTC emollients for atopic dermatitis (AD) that resulted in cost savings by reducing hospital and outpatient visits along with prescription costs, and other care expenses.

Therefore, the factors mentioned above are attributed collectively to the studied market growth. However, side effects associated with the OTC medications are projected to hamper the market growth slightly over the forecast period.

Dermatological OTC Drugs Industry Overview

The dermatological OTC drugs market is moderate in nature due to the presence of companies operating globally as well as regionally. The competitive landscape includes an analysis of international as well as local companies which hold market shares and are well known including Perrigo Company plc, Bausch Health Companies Inc., Galderma, and Johnson & Johnson, among others.

Dermatological OTC Drugs Market Leaders

  1. Perrigo Company plc

  2. Bausch Health Companies Inc.

  3. Johnson & Johnson

  4. Bayer AG

  5. Galderma

  6. *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competitors?
Download PDF

Dermatological OTC Drugs Market News

  • In February 2022, Galderma and Taro Pharmaceutical Industries Ltd. signed a definitive agreement for Taro to acquire Alchemee, formerly The Proactiv Company (TPC), from Galderma. The agreement between Galderma and Taro includes Alchemee's business and assets around the world, including the Proactiv brand. Taro Pharmaceutical Industries Ltd. has a broad portfolio of over-the-counter dermatology products.
  • In September 2021, Zelira Therapeutics launched RAF FIVE, through its dermatology subsidiary Ilera Derm LLC ("Zelira Dermatology") in the United States. The five-product RAF FIVE line consists of the Wash Away Gel Cleanser Acne Treatment, Spot On Acne Treatment, Kick-Off Hydrating Lotion Broad Spectrum SPF 30 Sunscreen, After Hours Moisturizing Lotion Acne Treatment, and Clear the Way Acne Treatment Pads.

Dermatological Otc Drugs Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Skin-related Diseases and Ageing Population
    • 4.2.2 Increasing Demand and Availability of Dermatological OTC Drugs
  • 4.3 Market Restraints
    • 4.3.1 Side Effects Associated With the OTC Products
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD Million)

  • 5.1 By Indication
    • 5.1.1 Acne
    • 5.1.2 Dermatitis
    • 5.1.3 Psoriasis
    • 5.1.4 Fungal Infections
    • 5.1.5 Others
  • 5.2 By Product
    • 5.2.1 Tablets and Capsules
    • 5.2.2 Oils, Gels, Creams, and Ointments
    • 5.2.3 Others
  • 5.3 By Route of Administration
    • 5.3.1 Oral
    • 5.3.2 Topical
  • 5.4 By Distribution Channel
    • 5.4.1 Hospital and Retail Pharmacies
    • 5.4.2 Online Pharmacies
    • 5.4.3 Others
  • 5.5 Geography
    • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
    • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Spain
    • 5.5.2.5 Italy
    • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle East and Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East and Africa
    • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Perrigo Company plc
    • 6.1.2 Bausch Health Companies Inc.
    • 6.1.3 Dr. Reddy's Laboratories
    • 6.1.4 Johnson and Johnson
    • 6.1.5 Bayer AG
    • 6.1.6 GlaxoSmithKline plc.
    • 6.1.7 Viatris Inc
    • 6.1.8 LEO Pharma A/S
    • 6.1.9 Acella Pharmaceuticals, LLC
    • 6.1.10 Teva Pharmaceutical Industries Ltd.
    • 6.1.11 Galderma
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Dermatological OTC Drugs Industry Segmentation

As per the scope of this report, dermatological over the counter drugs are referred to as non-prescription drugs. These medicines can be bought by an individual without a doctor's prescription and are safe for consumption without the doctor's consent. The Dermatological Over the Counter (OTC) Drugs Market is Segmented by Indication (Acne, Dermatitis, Psoriasis, Fungal Infections, and Others), Product (Tablets and Capsules, Oils, Gels, Creams, And Ointments, and Others) Route Of Administration (Oral and Topical), Distribution Channel (Hospital and Retail Pharmacies, Online Pharmacies, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Indication Acne
Dermatitis
Psoriasis
Fungal Infections
Others
By Product Tablets and Capsules
Oils, Gels, Creams, and Ointments
Others
By Route of Administration Oral
Topical
By Distribution Channel Hospital and Retail Pharmacies
Online Pharmacies
Others
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Dermatological Otc Drugs Market Research FAQs

What is the current Global Dermatological OTC Drugs Market size?

The Global Dermatological OTC Drugs Market is projected to register a CAGR of 4.3% during the forecast period (2025-2030)

Who are the key players in Global Dermatological OTC Drugs Market?

Perrigo Company plc, Bausch Health Companies Inc., Johnson & Johnson, Bayer AG and Galderma are the major companies operating in the Global Dermatological OTC Drugs Market.

Which is the fastest growing region in Global Dermatological OTC Drugs Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Global Dermatological OTC Drugs Market?

In 2025, the North America accounts for the largest market share in Global Dermatological OTC Drugs Market.

What years does this Global Dermatological OTC Drugs Market cover?

The report covers the Global Dermatological OTC Drugs Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Global Dermatological OTC Drugs Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Global Dermatological OTC Drugs Industry Report

Statistics for the 2025 Dermatological OTC Drugs market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Dermatological OTC Drugs analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

Dermatological OTC Drugs Market Report Snapshots

Dermatological OTC Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)